Affordable Access

Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure.

Authors
  • Silver, Marc A
  • Horton, Darlene P
  • Ghali, Jalal K
  • Elkayam, Uri
Type
Published Article
Journal
Journal of the American College of Cardiology
Publisher
Elsevier
Publication Date
Mar 06, 2002
Volume
39
Issue
5
Pages
798–803
Identifiers
PMID: 11869844
Source
Medline
License
Unknown

Abstract

Treatment of decompensated CHF with nesiritide may lead to lower healthcare costs and reduced mortality compared to treatment with dobutamine.

Report this publication

Statistics

Seen <100 times